Mercer Global Advisors
CTOR

Mercer Global Advisors’s Citius Oncology CTOR Stock Holding History

Mercer Global Advisors’s Portfolio CTOR Stock Details CTOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$130 Buy
+200
New +$159 ﹤0.01% 5950

Other funds holding CTOR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.6B AUM 30.67% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Mercer Global Advisors's CTOR Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Citius Oncology (CTOR) in Q2 2026: 200 shares worth $130. The stake represents ﹤0.01% of the portfolio and ranks #5950 among its holdings.

7 funds tracked by Wall St. Rank hold CTOR as of Q2 2026.

  • Mercer Global Advisors held 200 shares of Citius Oncology worth $130 as of Q2 2026.
  • Citius Oncology was a new Mercer Global Advisors position in Q2 2026.
  • Citius Oncology made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5950 holding.
  • 7 funds tracked by Wall St. Rank held Citius Oncology as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.